CTRI/2017/05/008606
Completed
未知
A Prospective Study To Evaluate Pelvic Bone Mineral Density Changes In Patients Of cervical Cancer Undergoing Chemoradiotherapy.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- 1.Histological diagnosis of cervical cancer.2.FIGO stage IB to IVA.3.Good performance status,Health Condition 2: C068- Malignant neoplasm of overlappingsites of other and unspecified parts of mouth
- Sponsor
- PGIMER
- Enrollment
- 106
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Histological diagnosis of cervical cancer.
- •2\.FIGO stage IB to IVA.
- •3\.Good performance status, suitable for curative chemoradiotherapy.
- •4\.Consenting for participation and follow up.
Exclusion Criteria
- •1\.Operated cases of cervical cancer.
- •2\.Previous history of pelvic irradiation.
- •3\.History of pelvic trauma.
- •4\.Patients on hormone replacement or long term corticosteroids.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
To evaluate spine-pelvis-lower extremity alignment using scanogram xrays in patients with knee osteoarthritisHealth Condition 1: M17- Osteoarthritis of kneeCTRI/2021/08/036088Pt B D Sharma PGIMS ROHTAK
Recruiting
Not Applicable
Prostate cancer and bone healthHealth Condition 1: null- Prostate cancer patients who presents to KGMU for treatment will be enrolled in the study.CTRI/2017/08/009451King George Medical University80
Recruiting
Not Applicable
Prospective exploratory study: Bone Mineral Density changes of the acetabulum after revision hip arthroplasty using bone impaction grafting.Gewrichtvervanging/reconstructie ne een primaire totale heup protheseBone mineral density after Bone impaction grafting10023213NL-OMON38760Rijnstate Ziekenhuis20
Completed
Not Applicable
A clinical study to evaluate the efficacy of bone-modyfying agent for the patients of prostate cancer.JPRN-UMIN000015126Department of Urology, Keio University School of Medicine
Active, not recruiting
Phase 1
study to assess the changes in bone health after changing from a TDF based regimen to Bicetegravir-Tenofovir Alafenamide-Emtricitavine based treatmentEUCTR2018-004499-36-ESConsorci Mar Parc de Salut de Barcelona60